Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
24 March 2016
Header
Header image
Highlight of the week

Highlight of the week

Webinars on IMI2 Call 9
24 March 2016

From 11 to 29 April 2016, IMI will hold webinars on each topic of the upcoming IMI2 9th Call for proposals, as well as one webinar on the IMI2 rules and procedures.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars are an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners to form a consortium. The webinar on IMI’s rules and procedures will also include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions.

To register, click here.

Read more

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
 
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
 
Please see the programmme for further details. Below, you can access the speakers' presentations:
 
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
 
 
Read more

Events Calendar

DIA 28th Annual EuroMeeting 2016
From 06/04/2016 to 08/04/2016 (Hamburg, Germany)

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer?

The DIA EuroMeeting is the premier platform on which to exchange ideas with thought leaders on key challenges and opportunities facing health care product development professionals. 

By attending EuroMeeting 2016, you will discuss issues while building relationships with your regulatory, industry and academia counterparts who are guiding the trends.

DOWNLOAD PROGRAMME

Read more

Events Calendar

ICH Info Day (this event is part of the pre-conference programme of the DIA EuroMeeting)
On 06/04/2016 (Hamburg, Germany)

This year’s Information Day will focus on the recent reforms within ICH and what this means for the global development of medicines. Participants will hear how ICH is moving towards becoming a truly global platform for regulators and industry, in order to achieve the objective of ‘Harmonisation for Better Health’.

Learn directly from the experts: 
Sessions include Q&A with: Dawn Ronan, Director of the ICH Secretariat; Tomas Salmonson EMA; and Richard Bergström, EFPIA, Belgium 

Read more

Events Calendar

EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Where do we currently stand with the implementation in different Member States
On 13/04/2016 (Brussels)

Organised by EFGCP with the partnership of EORTC

A revision of the Clinical Trials Regulation was adopted by European legislation makers in 2014. This revised legal framework will bring significant advances compared with today’s situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017).

For more information about the programme, please click here.

Read more

Events Calendar

Certificate in European Healthcare Compliance Ethics & Regulation
From 06/06/2016 to 10/06/2016 (Paris)

The pharmaceutical, biotech and medical device industries increasingly are facing a more challenging regulatory and enforcement landscape throughout Europe. This intensive, multi-day educational and training certification in healthcare compliance addresses the myriad of legal, regulatory and compliance issues faced by pharmaceutical, biotech and medical device manufacturers working in healthcare compliance in Europe.

Read more

Documents

From our blog

Report on a meeting between the EFPIA HTA WG and DG SANTE on 16 February 2016
24 March 2016 (Publications)

On 16 February 2016 DG SANTE was invited to the EFPIA Working Group on HTA. The purpose of the meeting was to present the EU [...] Read more

What we are reading

What we are reading

Launch of new European Stem Cell Bank
24 March 2016 (EBiSC)

EBiSC, the European Bank for induced pluripotent Stem Cells announces the public launch of its online catalogue of induced Pluripotent Stem Cells (iPSCs) which are available to academic and commercial scientists for use in disease modelling and other forms of pre-clinical research. (https://cells.ebisc.org).

Read more

What we are reading

Brexit could complicate marketing status of drugs, new licenses
24 March 2016 (BIOPharma DIVE)

A decision by the U.K. to leave the E.U. would likely complicate the status of drugs approved under E.U. marketing authorizations, Reuters reports. Authorizations can only be held by companies located within the E.U., and a 'Brexit' would jeopardize the five-year initial licensing for new drugs—i.e. a drug winning approval one year before a U.K. departure might lose those remaining four years. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail